Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Y Dirix

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2025
Multiscale Modeling Uncovers Macrophage Infiltration and TNF-α Signaling Networks for Targeting in Inflammatory Breast Cancer Tumor EmboliPritha Pai, Christophe Van Berckelaer, Steven Van Laere, et al.
Breast Cancer Research and Treatment|October 26, 2005
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancerGert G Van den Eynden, Steven J Van Laere, Ilse Van der Auwera, et al.
Breast Cancer Research and Treatment|September 21, 2005
Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysisSteven Van Laere, Ilse Van der Auwera, Gert G Van den Eynden, et al.
Plos One|July 30, 2011
Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinomaXuan Bich Trinh, Wiebren A A Tjalma, Luc Y Dirix, et al.
Neoplasia (New York, N.Y.)|June 14, 2017
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.
Angiogenesis|January 15, 2019
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastasesBoris Galjart, Pieter M H Nierop, Eric P van der Stok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-bindingSteven J Van Laere, Ilse Van der Auwera, Gert G Van den Eynden, et al.
Cancer Letters|December 3, 2014
Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancerDieter J E Peeters, Anja Brouwer, Gert G Van den Eynden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancerHarold J Burstein, Yan Sun, Luc Y Dirix, et al.
Cancer|June 14, 2012
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 studyBrian Rini, Cezary Szczylik, Nizar M Tannir, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|June 12, 2025
Multiscale Modeling Uncovers Macrophage Infiltration and TNF-α Signaling Networks for Targeting in Inflammatory Breast Cancer Tumor EmboliPritha Pai, Christophe Van Berckelaer, Steven Van Laere, et al.
Breast Cancer Research and Treatment|October 26, 2005
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancerGert G Van den Eynden, Steven J Van Laere, Ilse Van der Auwera, et al.
Breast Cancer Research and Treatment|September 21, 2005
Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysisSteven Van Laere, Ilse Van der Auwera, Gert G Van den Eynden, et al.
Plos One|July 30, 2011
Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinomaXuan Bich Trinh, Wiebren A A Tjalma, Luc Y Dirix, et al.
Neoplasia (New York, N.Y.)|June 14, 2017
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)Madhura Joglekar-Javadekar, Steven Van Laere, Michael Bourne, et al.
Angiogenesis|January 15, 2019
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastasesBoris Galjart, Pieter M H Nierop, Eric P van der Stok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-bindingSteven J Van Laere, Ilse Van der Auwera, Gert G Van den Eynden, et al.
Cancer Letters|December 3, 2014
Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancerDieter J E Peeters, Anja Brouwer, Gert G Van den Eynden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancerHarold J Burstein, Yan Sun, Luc Y Dirix, et al.
Cancer|June 14, 2012
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 studyBrian Rini, Cezary Szczylik, Nizar M Tannir, et al.
Pageof 9